DrazCanna, Inc.

Equities

DZCA

US8257842000

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 12:22:07 2024-05-15 pm EDT			5-day change	1st Jan Change
0.043 ^USD	-71.12%		0.00%	-88.53%

2023	EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	CI
2023	Drazcanna, Inc. Announces CEO Changes	CI

Sibling Group Holdings, Inc. Terminates Richard Marshall as Chief Development Officer

June 01, 2015 at 02:33 pm EDT

On May 26, 2015, Sibling Group Holdings, Inc. eliminated the position of Chief Development Officer as part of the company's management restructuring. Mr. Richard Marshall held the Chief Development Officer position at this time, and his employment with the company was terminated as a result.

Latest news about DrazCanna, Inc.

EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	Nov. 29	CI
Drazcanna, Inc. Announces CEO Changes	Nov. 02	CI
Drazcanna, Inc. Announces CFO Changes	Nov. 02	CI
Drazcanna, Inc. Announces Executive Changes	Nov. 02	CI
Sibling Group Holdings, Inc. Announces Resignation of David W. Saba as Chief Operating Officer	16-03-30	CI
Global Personalized Academics Announces Expansion Plans	15-12-22	CI
Sibling Group Holdings Seeks Acquisitions	15-11-09	CI
Sibling Group Holdings, Inc. Announces Executive Appointments	15-11-05	CI
DrazCanna, Inc. Auditor Raises 'Going Concern' Doubt	15-10-22	CI
Sibling Group Holdings, Inc. Announces New Appointments, Effective July 20, 2015	15-07-20	CI
Sibling Group Holdings, Inc. Terminates Richard Marshall as Chief Development Officer	15-06-01	CI
Sibling Group Holdings, Inc. Announces Management Changes	15-05-18	CI
Sibling Group Holdings, Inc. Announces Demise of Maurine Findley, Chairman of Board of Directors	15-05-07	CI
Sibling Group Holdings, Inc. Announces Formation of Strategic Partnership and Completion of $3.75 Million Funding from Shenzhen City Qianhai Xinshi Education Management Co., Ltd	15-03-06	CI
Sibling Group Holdings, Inc. announced that it has received $0.1 million in funding.	15-02-26	CI
Sibling Group Holdings, Inc. Announces Executive Changes	15-01-30	CI
Sibling Group Holdings, Inc. completed the acquisition of the assets of Urban Planet Media & Entertainment Corp.	15-01-29	CI
Sibling Group Holdings, Inc. announced that it has received $0.25 million in funding from FireRock Capital, Inc.	14-12-04	CI
Sibling Group Holdings, Inc. announced that it expects to receive $0.25 million in funding from FireRock Capital, Inc.	14-11-30	CI
Sibling Group Holdings, Inc. cancelled the acquisition of the assets and operations EDEVATE.	14-11-17	CI
Sibling Group Holdings, Inc. signed a non-binding letter of intent to acquire the assets of Urban Planet Media & Entertainment Corp.	14-10-29	CI
Sibling Group Holdings, Inc. Appoints Jed Friedrichsen to Academic Advisory Board	14-09-16	CI
Sibling Group Holdings, Inc. Announces Management Changes	14-06-25	CI
Sibling Group Mulls Acquisitions	14-06-25	CI
Sibling Group Holdings, Inc. completed the acquisition of assets and operations of Blendedschools.net.	14-05-29	CI

Chart DrazCanna, Inc.

Duration

Period

More charts

Company Profile

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
DRAZCANNA, INC.	-88.53%	1.43M
MODERNA, INC.	+28.66%	49.18B
IQVIA HOLDINGS INC.	+0.96%	42.11B
LONZA GROUP AG	+50.47%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+13.38%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.60%	18.71B
BIO-TECHNE CORPORATION	+8.07%	13.26B
MEDPACE HOLDINGS, INC.	+32.17%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.37%	11.99B

Other Biotechnology & Medical Research